Trump and Biden Aren't Free Traders, so What's the Difference?

For the marginally creditworthy, mandatory interest rate caps on credit cards would end access to a convenient form of credit. Nick Anthony discusses his essay in Cato's new book, The War on Prices. Hosted on Acast. See acast.com/privacy for more information.

It's not exactly a silver lining, but data from the pandemic has some lessons in it about the effectiveness of price gouging laws. Gavin Roberts, an economist at Weber State University, discusses his findings. Hosted on Acast. See acast.com/privacy for more information.

As smaller local newspapers continue to shrink, what's the potential for AI to help deliver local news to happy customers? Paul Matzko makes his hopeful case to foster a better-informed public. Hosted on Acast. See acast.com/privacy for more information.

European leaders think very differently than US officials about China, both as a rising economic power and a military threat. Doug Bandow discusses why. Hosted on Acast. See acast.com/privacy for more information.

Ideological commitments shouldn't harm your ability to receive medical treatment. Erec Smith and Jeff Singer discuss a troubling evolution in how medical education is delivered in the US. Hosted on Acast. See acast.com/privacy for more information.

There aren't big, glaring differences between Trump and Biden on giving Americans maximum freedom to trade across the globe, but the style of the candidates' protectionism differs somewhat. Scott Lincicome explains. Hosted on Acast. See acast.com/privacy for more information.

Medicare represents a massive fraction of the federal budget, and its spending is effectively on autopilot. That needs to change sooner than later. Paragon Health Institute chief Brian Blase and Cato's Michael Cannon comment. Hosted on Acast. See acast.com/privacy for more information.

New regulations under consideration would hold financial advisors accountable to elements of the Bank Secrecy Act, which currently compels banks to turn over certain financial data to the feds. How would that change your relationship with that advisor? Jennifer Schulp comments. Hosted on Acast. See acast.com/privacy for more information.

The DEA is likely to change its federal designation for cannabis in the coming months. It's a good sign for research and for the ability of Americans to receive medical treatments involving the plant, but descheduling and ending federal prohibition is still a worthy goal. Jeff Singer explains. Hosted on Acast. See acast.com/privacy for more information.

How productive is federal spending to advance early childhood education? Following her testimony on Capitol Hill, Cato's Colleen Hroncich says there are several problems with the assumptions about its benefits. Hosted on Acast. See acast.com/privacy for more information.